Newsroom

UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.

Option Finance (26.03.2021) – Impact investing – investing with the intention of having a positive impact on the environment and society – originated in the private equity market but is now spreading to all asset classes.

Institutional Money (06.04.2021) - The unprecedented nature of the pandemic paved the way for aggressive and, at times, unorthodox stimulus measures; however, these were crucial for ensuring smooth market functioning and delivering accommodative financial conditions at the height of the crisis.

Bilan (31.03.2021) - As vaccines offer a way out of the current crisis, we should see a greater rebound among small and mid-cap companies, the so-called ‘SMID-cap’ segment, than in the broader market.

Good With Money (19.03.2021) – Mathieu Nègre, Head of Global Emerging Markets at UBP, recently took part in a Good With Money podcast, a series in which experts discuss current ethical investment trends.

 我们提供独具特色的全权委托投资组合管理服务，助您达成独一无二的目标和愿望。 

Asia Macro - A transformative shift towards self-sufficiency

Finanz und Wirtschaft (20.03.2021) - Gold prices declined in recent weeks to lows of around $1,680 per ounce. The cause was the continued steepening of the US yield curve.

Distressed investment opportunities offer a gateway to companies in financial trouble that need restructuring in order to survive.

A new partnership between UBP and amLeague, a specialised index provider, allows investors to combine the advantages of active investment management with those of passive index tracking. 

Union Bancaire Privée strengthens its Small and-Mid Cap franchise with the launch of a Global SMID Cap Equity strategy

Asia Macro - On a GDP-weighted basis, Asia is expected to expand by 6.6% in 2021, up from a -1.0% contraction in 2020.